We are live on
!
Find out more
Dianthus Therapeutics
DNTH
DNTH
97 hedge funds and large institutions have $366M invested in Dianthus Therapeutics in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 39 increasing their positions, 22 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
78% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 9
77% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 22
8% more funds holding
Funds holding: 90 → 97 (+7)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.55% less ownership
Funds ownership: 4.55% → 4% (-0.55%)
12% less capital invested
Capital invested by funds: $418M → $366M (-$52.1M)
Holders
97
Holders Change
+7
Holders Change %
+7.78%
% of All Funds
1.69%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
39
Reduced
22
Closed
9
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$556K
Top Buyers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$12.8M |
| 2 |
O
OrbiMed
New York
|
+$12.5M |
| 3 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$2.12M |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
+$2.11M |
| 5 |
BlackRock
New York
|
+$2.03M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$7.31M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$2.18M |
| 3 |
ACM
Altium Capital Management
New York
|
-$1.95M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.4M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$1.24M |
